Home > PJ (current issue) > Christmas Miscellany 2004 | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7330 p930-931
18/25 December 2004

This article
Reprint   Photocopy

PDF 180K, Acrobat Reader


Christmas miscellany summary

Gold, golf and pharmacy in the Gulf

Having recently revisited the country of his birth, Sultan Dajani tells of developments in the United Arab Emirates


Sultan (SID) Dajani, MRPharmS, is a community pharmacist and member of the Council of the Royal Pharmaceutical Society. He also serves on the Pharmaceutical Services Negotiating Committee and the local pharmaceutical committee for Lambeth, Southwark and Lewisham

Gulf

According to legend, when a gazelle cried in the Abu Dhabi desert, an oasis was born and this became known as Al-Ein

Visitors to the Gulf who expect year round sunshine, white beaches, undulating desert sands, world class shopping, diverse cuisines, live entertainment and an unlimited range of recreational pursuits are rarely disappointed. For those in love with carats of the gold variety, the Gulf is paradise. This is where you will find 22-carat gold about a third cheaper than the 18-carat versions in the UK. And haggling in English is expected.

The United Arab Emirates (UAE) is a federation of seven states, which include Abu Dhabi and Dubai. Dubai is cosmopolitan but Abu Dhabi is the only place to be if you want to play golf in the footsteps of Faldo, Montgomery and other golfing heroes — the World Golf Sand Championships were held there recently. But do not expect to find any greens. There are only browns and you need an artificial grass mat to tee off. However, no course is without the requisite 19th hole!

Development

The federation was formed in 1971. Under the presidency of Sheikh Zayed Bin Sultan Al Nahayan, the UAE has made gargantuan architectural, structural and economic achievements, through ambitious vision and having the resources to realise this. There have been similar unrelenting advances in societal aspects, too. This includes a burgeoning health care system. When I visited Abu Dhabi recently I hardly recognised the place. Admittedly, I had only just started walking when my family left, but it would be just as unrecognisable had we left only 10 years ago. I am glad to say that the place has changed for the better.

Although Abu Dhabi is the capital of the federation, Dubai is considered the commercial hot-bed of the Middle East. Served by more than 200 shipping lines and with airline links to over 130 cities, it is the gateway to a billion people whose annual market value is estimated at almost £70bn per annum.

Here, the pharmaceutical market is about 4 per cent greater than the global average and, because Dubai has an open market with no exchange controls, quotas or trade barriers, it is easier to do business. The UAE is a launch-pad to the Middle East and Africa so it is not surprising that a great deal of importance is placed on the Middle Eastern health market. This is reflected by the region playing host to one of the busiest and most comprehensive health conferences in the world: the Arab Health Conference.

Now in its 28th year and held in Dubai, the Arab Health Conference is considered to be a vital showcase for many new products and innovative services. Hosting 1,500 exhibitors and involving 25 countries it is no wonder that it has become so renowned and is reputed to be the breaking ground for many new companies. Furthermore, the conference acts as a forum for exchanging ideas and facilitating the development of health care through five areas, namely “medlab” (clinical testing), pharmaceuticals, dentistry, international health services and hospital design and interiors.

In addition, work to build a health care city in Dubai is currently under way. This is to become the region’s centre of excellence for specialist medical services, medical education, life science research and technology leveraged health care services. Dubai Healthcare City will have the capacity to accommodate 15 million visitors each year and, all being well, should be completed in five years. The first four buildings of phase I are to be inaugurated on Christmas day this year.

Apart from having fewer resource problems than other countries, the main advantage the UAE has is that, as a new country, it starts with a clean slate — unlike the NHS in the UK, it does not have to make the best out of an old system and is not embedded in any particular culture. Materials are new and the processes are not over burdened. Ongoing expansion of hospitals, laboratories, medical research centres and specialist medical facilities will make the ideals of equity and choice attainable.

However, in a land of plenty sometimes logic can be in short supply. For example, the health care available to the large migrant manual labour workforce is expensive and choice is a luxury. So, many who fall ill are forced to return to their place of origin for treatment — an anathema to any civilisation that wishes to become a first class society. To overcome this problem, a workable national health insurance scheme is being developed.

Pharmacy, UAE style

The practice of pharmacy in hospitals, as in the UK, varies significantly between institutions, especially in their relationships with the community (eg, the services they commission from primary care). The American Hospital in Dubai was the first hospital to be accredited by the American Society of Health-system Pharmacists (ASHP) and the Joint Commission for International Accreditation (JCIA). For example, all intravenous medicines are prepared in accordance with the latest ASHP and JCIA standards. Medicines are distributed to patients on the wards in “unit dose systems”. This means that for each ward round the medicines for each patient are individually packaged. The pharmacy staff at the American Hospital are also responsible for preparing total parenteral nutrition.

Pharmacists deliver the required discharge medicines to patients, provide medicines management information and answer any queries. Medication errors and adverse drug reaction are all reported and all the necessary procedures are in place relating to alerts, correcting errors and educating hospital staff in order to prevent such incidents reoccurring. Other work includes evaluation of antibiotic use, data collection, formulation, producing pharmacy and therapeutic committee bulletins and the performance improvement committee with recommendations for corrective action (eg, risk assessment). All these activities are documented.

Many hospitals in the UAE work collaboratively with Ajman University’s college of pharmacy, where education and training manuals are prepared to ensure high quality training for preregistration trainees. Pharmacy staff are requested to keep up to date with new information through continuing education. Continuing professional development is not practised and long-distance learning is not part of the educational landscape.

However, the American Hospital is one of the better examples of hospital pharmacy. In the UAE, pharmacists are looked at in much the same sense as technicians are in the UK because their skills remain untapped. There is little consistency of service, no inspectors and no official ethical guidance document. It is also surprising to learn that part-time postgraduate qualifications are not as esteemed as the full-time equivalent. This is reflected in terms of responsibilities given.

Nevertheless, progress is being made. The UAE may be a long way from pharmacist prescribing, pharmacist-run medicines management clinics and electronic patient records but, if as much energy is devoted to public health as it is to engineering, it will catch up quickly and could soon become a world leader.

The UAE’s open market (apart from Dubai, which opted out) is regulated by the Directorate of Drug Control in co-operation with the General Secretariat of Municipal-ities. This is a valuable measure because the market attracts numerous pharmaceutical products and food supplements and, therefore, needs to be regulated. Under the personal control of the director, Easa Bin Jakka Al Mansoori, the drug control department issues guidance to protect patients while also encouraging the highest quality pharmaceutical services in the Emirates.

Future plans for pharmacy include:

· Developing a financially independent agency for the control of medicines and medical devices
· A pharmacy board to oversee the professional side of pharmacy
· More resources for inspection and enforcement
· More UAE nationals to qualify and work as pharmacists
· A transparent legal mechanism for enforcing the powers given to drug control in the 1983 law and, ideally, a modernised law and legislature for medicines and pharmacy

Back to Top


©The Pharmaceutical Journal